People with cyclothymia often experience periods of depression followed by periods of hypomania, which is a milder form of mania.
The symptoms of cyclothymia can be disruptive to daily life and relationships. The depressive symptoms may include feelings of sadness, hopelessness, low energy, changes in appetite or sleep patterns, and difficulty concentrating. The hypomanic symptoms may include an inflated sense of self-esteem, decreased need for sleep, increased talkativeness, and a sudden increase in goal-oriented activity.
Managementof cyclothymia involves several strategies. Firstly, it is important to identify any triggers that may cause mood swings and work on developing coping mechanisms to deal with them. This may include lifestyle changes such as moderation in caffeine, avoiding drugs and alcohol or involving in regular physical exercise.
It is also important to establish healthy sleep patterns, and seek regular support treatment from a medical professional. Patient-guided physician treatment can be very effective in managing cyclothymia’s symptoms. Prescription of mood-stabilizing medication such as Lithium, Carbamazepine, and Valproate can play a crucial role in managing and balancing mood swings.
Psychological treatment options, such as CBT (cognitive behavioural therapy), can also help by teaching patients coping skills, distress tolerance and increasing insight into mood swings.
In conclusion, cyclothymia can be a complex mental health issue, but it is manageable with treatment and medication. However, it must be treated seriously and managed to decrease complications, and ultimately enhance the daily lifestyle of individuals suffering the disorder. A united front between patients, families, support groups, medication, and therapy teams is an integral part of the management of cyclothymia.
For those experiencing symptoms, it is essential to seek professional help from a health care practitioner early on in the course of the disease.

Submit an enquiry if you have more questions or make a referral today.